Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DocMorris AGXSWX:DOCM +17.25%65 Days Sales Outstanding is 17.68 as of Jun. 2025, which is 40% below its 10-year median of 29.68. GuruFocus rates XSWX:DOCM with a GF Score™ of 65/100 and a GF Value™ of CHF10.61 (Fairly Valued). The stock has 8 warning signs investors should review. Among 657 Healthcare Providers & Services companies, DocMorris AG ranks better than 83.41% on this metric.
DocMorris AG's average Accounts Receivable for the
six
months ended in Jun. 2025 was CHF52 Mil. DocMorris AG's Revenue for the
six
months ended in Jun. 2025 was CHF541 Mil.
Hence, DocMorris AG's Days Sales Outstanding for the
six
months ended in Jun. 2025 was 17.68.
The historical rank and industry rank for DocMorris AG's Days Sales Outstanding or its related term are showing as below:
XSWX:DOCM'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.38 Med: 29.68 Max: 51.23
Current: 18.38
During the past 13 years, DocMorris AG's highest Days Sales Outstanding was 51.23. The lowest was 18.38. And the median was 29.68.
XSWX:DOCM's Days Sales Outstanding is ranked better than 83.41% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 47.19
vs XSWX:DOCM: 18.38
DocMorris AG's Days Sales Outstanding
declined
from Jun. 2024 (20.39) to Jun. 2025 (17.68).
DocMorris AG (XSWX:DOCM) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
DocMorris AG Days Sales Outstanding Related Terms
DocMorris AG Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for DocMorris AG's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG Days Sales Outstanding Competitor Comparison
For the Pharmaceutical Retailers subindustry, DocMorris AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocMorris AG Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where DocMorris AG's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG (XSWX:DOCM) has a Days Sales Outstanding of 17.68 as of Jun. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on DocMorris AG and its competitors. This is 40% below median its historical median of 29.68. Over the past decade, DocMorris AG's Days Sales Outstanding has ranged from 18.38 to 51.23. According to the industry distribution chart, DocMorris AG ranks #109 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 16.6%.
Is DocMorris AG's Days Sales Outstanding too high?
DocMorris AG's current Days Sales Outstanding of 17.68 is 40% below median its 10-year median of 29.68. Over the past 10 years, this metric has ranged from a low of 18.38 to a high of 51.23. The Healthcare Providers & Services industry median Days Sales Outstanding is 47.19. DocMorris AG's value of 17.68 is 62.5% below this industry median. Based on the distribution chart, DocMorris AG ranks #109 out of 657 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DocMorris AG has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's Days Sales Outstanding compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DocMorris AG ranks #109 out of 657 companies for Days Sales Outstanding. This places DocMorris AG in the top 17% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 47.19. DocMorris AG's value of 17.68 is 62.5% below this benchmark. Historically, DocMorris AG's own Days Sales Outstanding has ranged from 18.38 to 51.23 over the past decade. While the company's 10-year median is 29.68 vs. the industry median of 47.19, DocMorris AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 47.19, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocMorris AG's current Days Sales Outstanding of 17.68 is 62.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on DocMorris AG and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 47.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocMorris AG's current Days Sales Outstanding is 17.68, which is 40% below median its own 10-year median of 29.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Fairly Valued. The stock's GF Value™ is CHF10.61, compared to a current price of CHF10.06 — trading 5.2% below its estimated fair value. The current Days Sales Outstanding is 17.68, which is 40% below median its 10-year median of 29.68 and 62.5% below the Healthcare Providers & Services industry median of 47.19. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current Days Sales Outstanding is 17.68 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued.
The current stock price of CHF10.06 is trading 5.2% below its estimated GF Value™ of CHF10.61.
GuruFocus considers DocMorris AG to be Fairly Valued.
Key valuation signals for XSWX:DOCM:
Days Sales Outstanding: 17.68 (40% below median its 10-year median of 29.68)
GF Value™: CHF10.61 vs. price of CHF10.06 (5.2% below fair value)
Industry Position: 62.5% below the Healthcare Providers & Services median (#109 of 657)
No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score
Get the complete analysis for XSWX:DOCM
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DOCM has been successfully added to your 
